NSE BSE
fermenta biotech limited stock

FERMENTA BIOTECH LIMITED Share Price

- - (%)
Sector: -

506414

FERMENTA

img img img img
No Data Available

FERMENTA BIOTECH LIMITED Share Price Update


As of the latest trading session, FERMENTA BIOTECH LIMITED share price is currently at 162.85, which is up by 1.65 from its previous closing. Today, the stock has fluctuated between 161.00 and 163.40. Over the past year, FERMENTA BIOTECH LIMITED has achieved a return of 7.53 %. In the last month alone, the return has been -6.92 %.

FERMENTA BIOTECH LIMITED Performance

Day Range

Low161.00 High163.40
163.25

52 Week Range

Low 132.30 High 214.00
163.25

Open Price

161.55

Prev. Close

161.20

Volume (Shares)

5679.00

Total traded value

9.27

Upper Circuit

195.90

Lower Circuit

130.60

Note: The current prices & values are delayed, Login to your account for live updates.

FERMENTA BIOTECH LIMITED Fundamentals


(Standalone)

Market Cap (Cr) 479.28
PE Ratio (TTM) 0.00
Book Value / Share 105.25
Beta 0.66
ROE 0.65%
EPS (TTM) 3.08
Dividend Yield 0.76%
Net Profit Qtr (Cr) 11.70

FERMENTA BIOTECH LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars DEC 2023 (Values in Cr)
Revenue 89.35
Operating Expense 74.14
Net Profit 11.70
Net Profit Margin (%) 13.09
Earnings Per Share (EPS) 4.05
EBITDA 29.07
Effective Tax Rate (%) 34.19
Particulars SEP 2023 (Values in Cr)
Revenue 51.31
Operating Expense 72.32
Net Profit -27.98
Net Profit Margin (%) -54.53
Earnings Per Share (EPS) -9.69
EBITDA -18.58
Effective Tax Rate (%) 0.00
Particulars JUN 2023 (Values in Cr)
Revenue 76.78
Operating Expense 74.04
Net Profit 4.79
Net Profit Margin (%) 6.23
Earnings Per Share (EPS) 1.66
EBITDA 15.24
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 100.59
Operating Expense 87.43
Net Profit -2.11
Net Profit Margin (%) -2.09
Earnings Per Share (EPS) -0.73
EBITDA 11.41
Effective Tax Rate (%) -170.51
Particulars DEC 2022 (Values in Cr)
Revenue 53.75
Operating Expense 71.16
Net Profit -58.06
Net Profit Margin (%) -108.01
Earnings Per Share (EPS) -20.13
EBITDA -49.80
Effective Tax Rate (%) 4.97
Particulars MAR 2023 (Values in Cr)
Revenue 328.91
Operating Expense 335.76
Net Profit -57.00
Net Profit Margin (%) -17.32
Earnings Per Share (EPS) -19.75
EBITDA -12.68
Effective Tax Rate (%) 1.67
Particulars MAR 2022 (Values in Cr)
Revenue 387.96
Operating Expense 352.93
Net Profit 30.24
Net Profit Margin (%) 7.79
Earnings Per Share (EPS) 10.48
EBITDA 83.46
Effective Tax Rate (%) 28.97
Particulars MAR 2021 (Values in Cr)
Revenue 372.82
Operating Expense 316.21
Net Profit 51.97
Net Profit Margin (%) 13.93
Earnings Per Share (EPS) 18.02
EBITDA 100.33
Effective Tax Rate (%) 17.80
Particulars MAR 2020 (Values in Cr)
Revenue 300.51
Operating Expense 265.27
Net Profit 63.67
Net Profit Margin (%) 21.18
Earnings Per Share (EPS) 22.07
EBITDA 81.81
Effective Tax Rate (%) -33.90
Particulars MAR 2019 (Values in Cr)
Revenue 404.67
Operating Expense 295.89
Net Profit 110.35
Net Profit Margin (%) 27.26
Earnings Per Share (EPS) 38.25
EBITDA 153.62
Effective Tax Rate (%) 8.89
Particulars MAR 2023 (Values in Cr)
Book Value / Share 109.03
ROE % -7.67
ROCE % -0.29
Total Debt to Total Equity 0.67
EBITDA Margin 7.58
Particulars MAR 2022 (Values in Cr)
Book Value / Share 129.00
ROE % 4.11
ROCE % 7.36
Total Debt to Total Equity 0.64
EBITDA Margin 17.69
Particulars MAR 2021 (Values in Cr)
Book Value / Share 125.00
ROE % 12.70
ROCE % 12.43
Total Debt to Total Equity 0.68
EBITDA Margin 24.10
Particulars MAR 2020 (Values in Cr)
Book Value / Share 107.27
ROE % 21.26
ROCE % 12.61
Total Debt to Total Equity 0.77
EBITDA Margin 26.80
Particulars MAR 2019 (Values in Cr)
Book Value / Share 272.90
ROE % 62.88
ROCE % 38.72
Total Debt to Total Equity 1.02
EBITDA Margin 39.99
Particulars MAR 2023 (Values in Cr)
Book Value / Share 115.77
ROE % 0.65
ROCE % 3.68
Total Debt to Total Equity 0.63
EBITDA Margin 14.36
Particulars MAR 2022 (Values in Cr)
Book Value / Share 137.26
ROE % 7.89
ROCE % 9.65
Total Debt to Total Equity 0.62
EBITDA Margin 21.74
Particulars MAR 2021 (Values in Cr)
Book Value / Share 128.42
ROE % 15.22
ROCE % 14.28
Total Debt to Total Equity 0.67
EBITDA Margin 27.19
Particulars MAR 2020 (Values in Cr)
Book Value / Share 108.36
ROE % 22.65
ROCE % 13.41
Total Debt to Total Equity 0.77
EBITDA Margin 27.54
Particulars MAR 2019 (Values in Cr)
Book Value / Share 271.74
ROE % 70.24
ROCE % 41.71
Total Debt to Total Equity 1.12
EBITDA Margin 38.12
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 58.27
Total Assets 635.80
Total Liabilities 635.80
Total Equity 311.88
Share Outstanding 29430987
Price to Book Ratio 0.92
Return on Assets (%) -8.09
Return on Capital (%) -9.74
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 33.60
Total Assets 706.84
Total Liabilities 706.84
Total Equity 371.45
Share Outstanding 29430987
Price to Book Ratio 1.50
Return on Assets (%) 2.18
Return on Capital (%) 2.54
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 44.53
Total Assets 687.07
Total Liabilities 687.07
Total Equity 360.29
Share Outstanding 28847322
Price to Book Ratio 1.95
Return on Assets (%) 6.62
Return on Capital (%) 7.72
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 33.10
Total Assets 613.67
Total Liabilities 613.67
Total Equity 309.44
Share Outstanding 28847322
Price to Book Ratio 1.96
Return on Assets (%) 9.69
Return on Capital (%) 11.55
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 91.13
Total Assets 551.24
Total Liabilities 551.24
Total Equity 250.56
Share Outstanding 9172792
Price to Book Ratio 3.03
Return on Assets (%) 21.30
Return on Capital (%) 26.34
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 55.04
Total Assets 664.65
Total Liabilities 664.65
Total Equity 334.07
Share Outstanding 29430987
Price to Book Ratio 0.92
Return on Assets (%) -8.65
Return on Capital (%) -10.44
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 30.74
Total Assets 712.64
Total Liabilities 712.64
Total Equity 395.97
Share Outstanding 29430987
Price to Book Ratio 1.50
Return on Assets (%) 4.24
Return on Capital (%) 4.78
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 41.30
Total Assets 682.53
Total Liabilities 682.53
Total Equity 370.44
Share Outstanding 28847322
Price to Book Ratio 1.95
Return on Assets (%) 7.61
Return on Capital (%) 8.66
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 32.36
Total Assets 609.61
Total Liabilities 609.61
Total Equity 312.60
Share Outstanding 28847322
Price to Book Ratio 1.96
Return on Assets (%) 10.44
Return on Capital (%) 12.27
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 90.73
Total Assets 550.97
Total Liabilities 550.97
Total Equity 249.48
Share Outstanding 9172792
Price to Book Ratio 3.03
Return on Assets (%) 20.02
Return on Capital (%) 24.8
Particulars MAR 2023 (Values in Cr)
Net Income -51.87
Cash from Operations 113.20
Cash from Investing -56.32
Cash from Financing -40.78
Net change in Cash 19.58
Free Cash Flow 153.69
Particulars MAR 2022 (Values in Cr)
Net Income 26.94
Cash from Operations 52.74
Cash from Investing -26.03
Cash from Financing -21.57
Net change in Cash -4.17
Free Cash Flow 89.87
Particulars MAR 2021 (Values in Cr)
Net Income 51.63
Cash from Operations 76.11
Cash from Investing -41.54
Cash from Financing -1.14
Net change in Cash 19.90
Free Cash Flow 131.38
Particulars MAR 2020 (Values in Cr)
Net Income 43.42
Cash from Operations 48.40
Cash from Investing -43.65
Cash from Financing -47.44
Net change in Cash -56.64
Free Cash Flow 116.87
Particulars MAR 2019 (Values in Cr)
Net Income 128.70
Cash from Operations 123.20
Cash from Investing -96.57
Cash from Financing 12.22
Net change in Cash 5.98
Free Cash Flow 158.97
Particulars MAR 2023 (Values in Cr)
Net Income -58.68
Cash from Operations 119.81
Cash from Investing -64.44
Cash from Financing -40.79
Net change in Cash 19.22
Free Cash Flow 160.29
Particulars MAR 2022 (Values in Cr)
Net Income 42.56
Cash from Operations 59.68
Cash from Investing -32.46
Cash from Financing -21.76
Net change in Cash -3.81
Free Cash Flow 96.81
Particulars MAR 2021 (Values in Cr)
Net Income 63.22
Cash from Operations 76.44
Cash from Investing -43.60
Cash from Financing -1.32
Net change in Cash 18.02
Free Cash Flow 131.36
Particulars MAR 2020 (Values in Cr)
Net Income 47.54
Cash from Operations 43.74
Cash from Investing -39.19
Cash from Financing -47.62
Net change in Cash -56.98
Free Cash Flow 107.55
Particulars MAR 2019 (Values in Cr)
Net Income 121.12
Cash from Operations 123.32
Cash from Investing -96.57
Cash from Financing 12.22
Net change in Cash 6.15
Free Cash Flow 159.09
Company Name Price P/E P/B Market Cap 52 Week Low/High
FERMENTA BIOTECH LIMITED 161.20 0.00 1.65 474.43 132.30 / 214.00
BLISS GVS PHARMA LTD 109.55 11.97 1.18 1146.89 71.00 / 148.95
CIPLA LTD 1399.35 26.53 4.23 112982.81 911.80 / 1519.00
GLAXOSMITHKLINE PHARMA LT 2291.55 56.12 21.83 38820.24 1265.00 / 2649.95
SANOFI INDIA LIMITED 8857.55 35.96 20.09 20398.94 6253.40 / 9370.35
Company Name Price P/E P/B Market Cap 52 Week Low/High
FERMENTA BIOTECH LIMITED 161.20 52.34 1.53 474.43 132.30 / 214.00
AMRUTAJAN HEALTH LTD 743.50 48.85 8.20 2149.51 556.05 / 802.60
ASTRAZENECA PHARMA IND LT 5757.75 90.25 21.97 14394.38 3131.10 / 7208.00
BLISS GVS PHARMA LTD 109.55 15.13 1.16 1146.89 71.00 / 148.95
ABBOTT INDIA LIMITED 26490.20 46.86 15.21 56291.68 20594.25 / 29628.15

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 161.50
  • 26 Days 166.70
  • 10 Days 162.90
  • 50 Days 168.80
  • 12 Days 164.00
  • 100 Days 165.30
  • 20 Days 166.50
  • 200 Days 144.30
161.58
PIVOT
First Resistance 164.32
Second Resistance 167.68
Third Resistance 170.42
First Support 158.22
Second Support 155.48
Third Support 152.12
RSI 27.81
MACD -2.75
Commodity Channel Index (CCI) -77.77
ADX 12.08
Williams % R -75.20

Over 1 Month

down

-6.92

Over 3 Months

down

-19.98

Over 6 Months

down

2.21

Over 1 Year

down

7.53

Over 3 Years

down

-20.06

Over 5 Years

down

-6.73

FERMENTA BIOTECH LIMITED Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

FERMENTA BIOTECH LIMITED Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
37.93
Promoter Holdings
62.06
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Krishna Datla Shareholding of Promoter and Promoter Group 1.0010225E7 34.01
Satish Varma Azad Nadimpally Shareholding of Promoter and Promoter Group 3453325.0 11.73
Anupama Datla Desai Shareholding of Promoter and Promoter Group 2561265.0 8.7
Preeti Thakkar Shareholding of Promoter and Promoter Group 2240376.0 7.61
Rakesh Kantilal Shah Public Shareholding 1020024.0 3.47
Kunal Ashok Kashyap Public Shareholding 612482.0 2.08
Rajeshwari Datla Public Shareholding 595818.0 2.02
Krishan Premnarayen Public Shareholding 405000.0 1.38

FERMENTA BIOTECH LIMITED

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-09-22 1.25 Final 2023-09-22 Equity shares 2022-08-04 1.25 Final 2022-08-05 Equity shares 2021-08-25 2.5 Final 2021-08-27 Equity shares 2019-11-22 5.0 Interim 2019-11-25 Equity shares 2019-06-28 1.25 Final 2019-07-02 Equity shares 2018-09-19 1.25 Final 2018-09-22 Equity shares 2017-09-21 2.5 Final 2017-09-23 Equity shares 2016-09-19 2.5 Final 2016-09-21 Equity shares 2014-09-10 2.5 Final 2014-09-12 Equity shares 2014-02-24 7.5 Interim 2014-02-25 Equity shares 2012-09-13 15.0 Final 2012-09-15 Equity shares 2012-07-05 15.0 Interim 2012-07-06 Equity shares 2012-02-23 15.0 Interim 2012-02-24 Equity shares 2011-09-15 10.0 Final 2011-09-17 Equity shares 2011-02-22 15.0 Interim 2011-02-23 Equity shares 2010-09-15 7.5 Final 2010-09-17 Equity shares 2010-06-03 7.5 Interim 2010-06-04 Equity shares 2009-09-17 7.5 Final 2009-09-19 Equity shares 2009-06-29 7.5 Interim 2009-06-30 Equity shares 2008-09-18 10.0 Final 2008-09-20 Equity shares 2007-09-06 5.0 Final 2007-09-08 Equity shares 2005-09-08 0.0 Final 2005-09-10 Equity shares
Ex-Date Ex-Bonus Ratio
2020-02-14 2020-02-13 2:1 2018-08-09 2018-08-08 1:1
Ex-Date Old FV NEW FV Record Date
2018-08-08 10.0 5.0 2018-08-09

Learn More About Stocks

About FERMENTA BIOTECH LIMITED

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by FERMENTA BIOTECH LIMITED

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Fermenta Biotech Ltd?

Answer Field

The share price of Fermenta Biotech Ltd for NSE is ₹ 0.00 and for BSE is ₹ 162.85.

What is the Market Cap of Fermenta Biotech Ltd?

Answer Field

The market cap of Fermenta Biotech Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 479.28 Cr. as of now.

What is the 52 Week High and Low of Fermenta Biotech Ltd?

Answer Field

The 52 Week High and Low of Fermenta Biotech Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 214.00 and ₹ 132.30.

How to Buy Fermenta Biotech Ltd share?

Answer Field

You can trade in Fermenta Biotech Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Fermenta Biotech Ltd?

Answer Field

The 1 year returns on the stock has been 7.53%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7 Lac+ Users

icon-with-text

4.3 App Rating

icon-with-text

4 Languages

icon-with-text

₹ 3800 Cr MTF Book

icon-with-text
loader